Ascort-12

Indication

• Autoimmune diseases (e.g., systemic lupus erythematosus, rheumatoid arthritis)
• Inflammatory conditions (e.g., inflammatory bowel disease)
• Allergic reactions (e.g., severe allergic reactions, asthma exacerbations)
• Replacement therapy for adrenal insufficiency (Addison’s disease)
• Musculoskeletal disorders (e.g., Duchenne muscular dystrophy)

Dosage and Administration

Route of Administration: Oral tablet.

Typical dose for adults and children: 12 mg once daily, or as prescribed based on the condition being treated.

For certain conditions: The dosage may vary, and the healthcare provider may adjust the dose based on the patient’s response and medical condition.

Tapering: For long-term use, gradual tapering may be required to avoid withdrawal symptoms.

Precautions

Avoid use in patients with known hypersensitivity to deflazacort or any component of the tablet.

Use cautiously in patients with a history of gastrointestinal disorders, infections, or mental health disorders (e.g., depression).

Long-term use can lead to side effects like osteoporosis, diabetes, and hypertension.

Not recommended for pregnant or breastfeeding women unless prescribed by a doctor.

Contraindications

Hypersensitivity to deflazacort or any excipient in the tablet.

Active or untreated infections (e.g., fungal infections).

Severe liver impairment.

Key Benefits

Effective Anti-Inflammatory Action: Reduces inflammation in a variety of conditions, providing relief from pain and swelling.

Immunosuppressive Effect: Helps manage autoimmune diseases by suppressing overactive immune responses.

Improved Quality of Life: Effective in managing chronic conditions, allowing patients to maintain daily activities.

Better Tolerability: Deflazacort is often associated with fewer side effects than other corticosteroids, particularly concerning weight gain and fluid retention.

Convenient Dosage: Once-daily 12 mg tablet formulation ensures ease of use for patients.